Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease

Abstract

Adalimumab is a potentially effective treatment for intestinal Behçet's disease in Japanese patients who are refractory to conventional treatments. ClinicalTrials.gov number: NCT01243671.